какво е besponsa за?
besponsa is indicated as monotherapy for the treatment of adults with relapsed or refractory cd22 positive b cell precursor acute lymphoblastic leukaemia all adult patients with philadelphia chromosome positive ph relapsed or refractory b cell precursor all should have failed treatment with at least 1 tyrosine kinase inhibitor tki